CASE DISCUSSION

Pneumonia in Immunocompromised Patients

Presented from India by Dr. Anusha C

Likes

1775

Views

Bookmarks

Case Description

Pneumonia in immunocompromised patients poses a significant risk due to their weakened defense mechanisms. These patients are more susceptible to opportunistic pathogens like fungi, viruses, and atypical bacteria. Symptoms may be subtle or atypical, making early diagnosis challenging. Treatment...

Case Summary

Pneumonia is a significant pulmonary complication in immunocompromised individuals, accounting for approximately 75% of such cases. Early and accurate diagnosis is crucial due to high morbidity and mortality rates. The increasing use of immunosuppressive agents in treating advanced cancers, connective tissue disorders, autoimmune diseases, and preventing graft rejection after transplants contributes to this issue.

Speaker Profile

Dr. Anusha C

Consultant Respiratory Physician, Manipal Hospital, Bangalore

Dr. Anusha. C, a highly skilled respiratory physician with extensive experience in managing COPD, bronchial asthma, ILD, tuberculosis, pneumonia, and sleep apnea, currently serves as a consultant at Manipal Hospital, Bangalore. With a keen interest in interventional pulmonology, sleep disorders, and airway diseases, she excels in procedures such as bronchoscopic lavage, TBLB, and thoracoscopy. Dr. Anusha's career includes roles at Suguna Hospital, Shree Uthradom Thirunal Academy of Medical Sciences, and Spectrum Diagnostic Center. She holds an MBBS from Rajarajeshwari Medical College and a Master's in Respiratory Medicine from JNMC, Belagavi, where she was awarded the best thesis of the year. Her academic contributions are highlighted by numerous journal publications and presentations at national and state conferences. Passionate about patient care and medical education, she has also managed the COVID ICU at SUT Medical College and initiated postgraduate courses in respiratory medicine. Dr. Anusha is an active member of several professional societies and has pursued specialized training in sleep medicine, tobacco cessation, and pediatric allergy and asthma

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.